{"url":"https://lda.senate.gov/api/v1/filings/627f2999-ee18-45d5-b17d-e929b8abcfee/","filing_uuid":"627f2999-ee18-45d5-b17d-e929b8abcfee","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2010,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.senate.gov/filings/public/filing/627f2999-ee18-45d5-b17d-e929b8abcfee/print/","filing_document_content_type":"text/html","income":null,"expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Lorina Marshall-Blake, Vice President-Government Relations","dt_posted":"2010-04-16T11:51:08.807000-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1901 MARKET STREET, 38TH FLOOR","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"PHILADELPHIA","registrant_state":"PA","registrant_zip":"19103","registrant":{"id":19172,"url":"https://lda.senate.gov/api/v1/registrants/19172/","house_registrant_id":33009,"name":"INDEPENDENCE BLUE CROSS","description":null,"address_1":"1901 MARKET ST., 38TH FLOOR","address_2":null,"address_3":null,"address_4":null,"city":"PHILADELPHIA","state":"PA","state_display":"Pennsylvania","zip":"19103","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"THOMAS HUTTON","contact_telephone":"+1 215-241-3842","dt_updated":"2022-04-06T16:06:15.473665-04:00"},"client":{"id":126308,"url":"https://lda.senate.gov/api/v1/clients/126308/","client_id":12,"name":"INDEPENDENCE BLUE CROSS","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"PA","state_display":"Pennsylvania","country":"US","country_display":"United States of America","ppb_state":"PA","ppb_state_display":"Pennsylvania","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2007-08-22"},"lobbying_activities":[{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"IRC section 833(b) tax provisions\nSections of Health Care Reform legislation pertaining to proposed annual insurer assessments, proposed excise tax on high-value health insurance plans, and proposed limitation of tax deduction for health insurer's executive compensation","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":19038,"prefix":null,"prefix_display":null,"first_name":"LORINA","nickname":null,"middle_name":null,"last_name":"MARSHALL-BLAKE","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Medicare Advantage","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":19038,"prefix":null,"prefix_display":null,"first_name":"LORINA","nickname":null,"middle_name":null,"last_name":"MARSHALL-BLAKE","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"Medicare Advantage Funding and Comparative Effectiveness Funding in Health Care Reform legislation","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":19038,"prefix":null,"prefix_display":null,"first_name":"LORINA","nickname":null,"middle_name":null,"last_name":"MARSHALL-BLAKE","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"HR 4489 \"To amend Chapter 89 of Title 5, United States Code, to ensure program integrity, transparency, and cost savings in the pricing and contracting of prescription drug benefits under the Federal Employees Health Benefit Program\"","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":19038,"prefix":null,"prefix_display":null,"first_name":"LORINA","nickname":null,"middle_name":null,"last_name":"MARSHALL-BLAKE","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"See attached addendum for General Lobbying Issue Area:  HCR - Healthcare Health Care Reform Bill HR3590 \"Patient Protection and Affordable Care Act\" parts pertaining to health care reform; Health\nCare Reconcilliation Bill HR 4872 \"The Health Care & Education Affordability Reconcilliation Act of 2010\" parts pertaining to\nhealth care reform; reasonable effective dates for comliance with insurance reforms; affordable premiums (insurer tax,\ninsufficient cost containment, weak mandate, restricted age discounts, insurer fees); federal health insurance rate authority;\nnational insurance exchange; grandfathering\n\nHealth Care Reform; Pathway to Covering America; Employer Based Healthcare System; Uninsured/Expanding Coverage;\nHealthcare Reform Modeling;\n\nInsurance Market Reform; Individual Market Reform; Small Group Market Reform; Small Business Healthcare; Guaranteed\nIssue; Community Rating; Health Status Rating; Health Savings Accounts/Medical Savings Accounts; Individual Manadate;\nMedical Loss Ratios; MEWAs;\n\nGovernment-run health insurance Plan; Government Plan Trigger; negotiated rates; state opt-out; Co-Ops; Medicare Payment\nRates; Provider Underpayments; Level Playing Field\n\nAffordable Private Health Care; proposed insurer fees; excise taxes on high value Plans; premium caps; 5 to 1 Age Rating Bands;\nRealistic Minimum Benefit Values; Effective Individual Mandate; Sherlock Report; Healthcare Delivery System Reforms;\nmalpractice reform; Oliver Wyman actuarial analysis \"Impact of the Patient Protection and Affordable Care Act on the Costs in\nthe Individual and Small-Employer Health Insurance Markets\"; CBO premium impact analysis\n\nNew federal regulatory functions; existing state regulatory functions; Federal Exchanges; Federal Connectors; Virtual\nConnectors; State Insurance Marts (SIMs); Pooling\n\nHealth Care Quality; Patient-centered Primary Care/Medical Home; Health Disparities; Wellness; Chronic Care Management;\nComparative Effectiveness Research; Improved Delivery of Health Care; evidence based care; Healthcare Delivery System\nReforms;\n\nHealth Information Technology Standards; Health Information Privacy; Electronic Health Records; Administrative\nSimplification\n\nAntitrust and Health Insurance Reform; McCarran-Ferguson antitrust exemption repeal legislation: HR 4626 \"Health Insurance\nIndustry Fair Competition Act\"\n\nScope of FEHBP preemption","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":19038,"prefix":null,"prefix_display":null,"first_name":"LORINA","nickname":null,"middle_name":null,"last_name":"MARSHALL-BLAKE","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}